1. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma
   Chao Yu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
2. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma
   Bo Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
3. Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma
   Gaoyang Chen et al, 2018, PLoS ONE CrossRef
4. Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples
   Xuan Dung Ho et al, 2017, Exp Biol Med (Maywood) CrossRef
5. Predicting novel genes and pathways associated with osteosarcoma by using bioinformatics analysis
   Bo Dong et al, 2017, Gene CrossRef
6. Long non‐coding RNA PGM5‐AS1 promotes epithelial‐mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR‐140‐5p‐mediated FBN1 inhibition
   Wei Liu et al, 2020, Mol Oncol CrossRef
7. DNA damage response and repair in osteosarcoma: Defects, regulation and therapeutic implications
   Fatemeh Sadoughi et al, 2021, DNA Repair CrossRef
8. PAIP1 is a novel oncogene in human hepatocellular carcinoma
   Nuobei Zhang et al, 2022, Discov Onc CrossRef
9. Paget’s Disease of the Bone and Lynch Syndrome: An Exceptional Finding
   Ana-Maria Gheorghe et al, 2023, Diagnostics CrossRef
10. Hsa_circ_0064636 regulates voltage dependent anion channel 1/ubiquitination factor E4A through miR‑326/miR‑503‑5 in osteosarcoma
    Guohua Yan et al, 2024, Oncol Lett CrossRef